Atossa Therapeutics logo

Atossa Therapeutics

ATOS | NASDAQ
Chart Builder DCF Calculator
$1.93
-$0.03 (-1.53%)
At close: Nov 16, 2026, 4:00 PM ET
$1.96
+$0.03 (+1.55%)
After-hours: Nov 16, 2026, 5:35 PM ET
-1.53%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
27.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #868/1021 (Top 85%)

Key Statistics

Market Data

Market Cap $19.26M
1D Range
1.86 2.09
52W Range
1.75 13.57

Valuation (TTM)

PE -0.50
PB 0.89
EV/EBITDA 0.04

Valuation (NTM)

Forward PE N/A
Forward PEG 0.05
Price Target $10.00
Loading financial charts...

Profile

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medicines. Their primary focus lies in addressing unmet medical needs in women's oncology, espec...

Sector Healthcare
Industry Biotechnology
Employees 16
IPO Date Nov 8, 2012
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$10.00
Upside
+418.13%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.